Prospect of OTC Viagra worries Heart Foundation

UPDATED: 29 May 2017 

The Heart Foundation is concerned about a bid to make erectile dysfunction drugs available over the counter.

The TGA is reviewing applications to give PDE-5 inhibitors sildenafil (including Viagra, Pfizer) and vardenafil (Levitra, Bayer) a Schedule 3 classification.

Heart Foundation Chief Medical Officer Professor Garry Jennings fears rescheduling will disrupt "the opportunity for

Latest

Trending